Systemic lupus erythematosus: The face of Asia

Annals of the New York Academy of Sciences

Volumn 1108, Issue , 2007, Pages 114-120

  Feng, Pao Hsii ^a  

^a TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

Asia; Cyclophosphamide; Mycophenolate mofetil; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB; STEROID; TACROLIMUS;

ASIA; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CONFERENCE PAPER; ETHNIC DIFFERENCE; HUMAN; HYPERTENSION; INFECTION; LOW DRUG DOSE; MORBIDITY; MORTALITY; OSTEOPOROSIS; PREVALENCE; PROGNOSIS; REGIONALIZATION; RELAPSE; SOCIOECONOMICS; STEM CELL TRANSPLANTATION; SURVIVAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

EID: 34948879106     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1422.013     Document Type: Conference Paper

References (26)

1. ALLISON, M.J., E. GERSZTEN, A.J. MARTINEZ, et al. 1977. Generalized connective tissue disease in a mummy from the Huari culture (Peru). Bull. N. Y. Acad. Med. 53: 292-301.
2. KAPOSI, M.I.C. 1872. Neue beitrage zur kenntniss des lupus erythmatosus. Arch. f. dermat. u. syph. 63: 1872.
3. OSLER, W. 1895. On the visceral complications of erythema exudativum multiforme. Am. J. Med. Sci. 110: 629-646.
4. HARGRAVES, M.M., H. RICHMOND & H. MORTEN. 1948. Presentation of two marrow elements: the 'Tart' cell and the 'LE' cell. Proc. Staff Meet. Mayo Clin. 23: 25-28.
5. SEAH, C.S., K.H. WONG, A.G.K. CHEW & F.J. JAYARATNAM. 1966. Cyclophosphamide in the treatment of systemic lupus erythematosus. Br. Med. J. 1: 333-335.
6. FENG, P.H., F.J. JAYARATNAM, E.P.C. TOCK & C.S. SEAH. 1973. Cyclophosphamide in the treatment of systemic lupus erythematosus. 7 years' experience. Br. Med. J. 2: 450-452.
7. AUSTIN, H.A., J.H. KLIPPEL, J.F. BALOW, et al. 1986. Therapy of lupus nephritis: controlled trial of prednisolone and cytotoxic drugs. N. Engl. J. Med. 314: 614-619.
8. BOEY, M.L., S.C. NG & P.H. FENG. 1987. Mortality of Orientals with systemic lupus erythematosus - a reappraisal. Singapore Med. J. 28: 318-320.
9. SINNIAH, R. & P.H. FENG. 1976. Lupus nephritis: correlation between light, electron microscopic and immunofluorescent finding and renal function. Clin. Nephrol. 6: 340-351.
10. FRANK, A.O. 1980. Apparent predisposition to systemic lupus erythematosus in Chinese patients in West Malaysia. Ann. Rheum. Dis. 39: 266-269.
11. SERDULA, A.M. & C.G. RHOADS. 1979. Frequency of systemic lupus in different ethnic groups in Hawaii. Arthritis Rheum. 22: 328-333.
12. KASLOW, R.A. 1982. High rate of death caused by systemic lupus erythematosus among U.S. residents of Asian descent. Arthritis Rheum. 25: 414-418.
13. SIEGEL, M., H.L. HOLLAY & S.C. LEE. 1970. Epidemiologic status on systemic lupus erythematosus; comparative data from New York City and Jefferson County, Alabama. 1956-1965. Arthritis Rheum. 13: 802-811.
14. CHAN, T.M., F.K. LI, C.S.O. TANG, et al. 2000. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. N. Engl. J. Med. 343: 1156-1162.
15. HOUSSIAU, F.A., C. VASCONCELOS & D. D'CRUZ. 2002. Immunosuppressive therapy in lupus nephritis; the Euro-Lupus Nephritis Trial; a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum. 46: 2121-2131.
16. LOONEY, R.J., J.H. ANOLIK, D. CAMPBELL, et al. 2004. B cell depletion as a novel treatment for systemic lupus erythematosus. Arthritis Rheum. 50: 2580-2586.
17. ARINGER, M., W.B. GRANINGER, G. STEINER & J.S. SMOLEN. 2004. Safety and efficacy of tumour necrosis factor-alpha blockade in systemic lupus erythematosus. Arthritis Rheum. 50: 3161-3169.
18. RAUOVA, L., J. LUKAC, Y. LEVY, et al. 2001. High-dose intravenous immunoglobulin for lupus nephritis - a salvage immunomodulation. Lupus 10: 209-213.
19. FU, L.W., L.Y. YANG, W.P. CHEN, et al. 1998. Clinical efficacy of cyclosporin A in the treatment of paediatric lupus nephritis with heavy proteinuria. Br. J. Rheum. 37: 217-221.
20. MOK, C.C., K.H. TONG, C.H. TO, et al. 2005. Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: an open labeled pilot study. Kidney Int. 68: 813-817.
21. PETRI, M. & R. BRODSKY. 2006. High-dose cyclophosphamide and stem cell transplantation for refractory systemic lupus erythematosus. JAMA 295: 559-560.
22. BURT, R.K., S.A. TRAYNOR, L. STATKUTE, et al. 2006. Non-myeloablative hemopoietic stem cell transplantation for systemic lupus erythematosus. JAMA 295: 527-535.
23. UROWITZ, M.B., D.M. IBANEZ & D.D. GLADMAN. 2005. Changing outcome in SLE over 35 years. Presented at 69th American College of Rheumatology Annual Meeting. Nov 12-17, San Diego, Calif. Abstract 1957.
24. SULE, S. & M. PETRI. 2006. Socio-economic status in systemic lupus erythematosus. Lupus 15: 720-723.
25. BRUCE, I.N., D.D. GLADMAN & M.B. UROWITZ. 2000. Factors associated with refractory renal disease in patients with systemic lupus erythematosus: the role of patient nonadherence. Arthritis Care Res. 13: 406-408.
26. LAU, A. & P.H. FENG. 2006. Living with the wolf. APLAR Jl Rheum. 9: 317-319.